Denileukin Diftitox Lyo 300 Mcg/vial Cit
Generic Name: denileukin diftitox lyo 300 mcg/vial cit
Dosage form: INJECTION. Active ingredients: DENILEUKIN DIFTITOX (300 ug/2mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: INJECTION. Active ingredients: DENILEUKIN DIFTITOX (300 ug/2mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as injection.
Related Medications
Arginine
arginine
Dosage form: POWDER. Active ingredients: ARGININE (1 kg/kg). Category: BULK INGREDIENT.
Mogamulizumab-kpkc
mogamulizumab-kpkc
Chemokine Receptor Type 4 Interaction [EPC]
11 DESCRIPTION Mogamulizumab-kpkc is a recombinant humanized monoclonal antibody that targets CC chemokine receptor 4 (CCR4)-expressing cells. Mogamulizumab-kpkc is an IgG1 kappa immunoglobulin that has a calculated molecular mass of approximately 149 kDa. Mogamulizumab-kpkc is produced by recombinant DNA technology in Chinese hamster ovary cells.
Vadadustat
vadadustat
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]
11 DESCRIPTION VAFSEO contains vadadustat, a hypoxia-inducible factor prolyl hydroxylase (HIF PH) inhibitor. Vadadustat is 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid. Vadadustat has a molecular weight of 306.70. The empirical formula is C 14 H 11 ClN 2 O 4 . The chemical structure is: Vadadustat is a white to off-white solid that is practically insoluble in water. Vadadustat is formulated as a film-coated, immediate-release tablet for oral administration.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.